Innate Pharma Stock
Innate Pharma Stock
We can see a decrease in the price for Innate Pharma. Compared to yesterday it has lost -€0.026 (-1.660%).
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | -1.660% | -1.282% | -4.110% | -19.203% | 0.654% | -44.505% | -46.528% |
| Nanobiotix | 5.260% | -1.983% | 3.701% | 459.401% | 76.021% | 348.865% | 175.574% |
| Poxel S.A. | 0.300% | 1.738% | -2.689% | -61.731% | -16.736% | -68.006% | -96.647% |
| Adocia | 0.050% | 4.692% | -4.058% | -44.833% | -39.818% | -34.563% | -58.321% |
